# Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

> **NCT04585074** · — · ACTIVE_NOT_RECRUITING · sponsor: **Severance Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Breast Neoplasms
- Germline BRCA1 Gene Mutation
- Germline BRCA2 Gene Mutation
- Benign Breast Disease
- Germline Mutation Abnormality

## Interventions

- **PROCEDURE:** Robotic or endoscopic nipple sparing mastectomy
- **PROCEDURE:** Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)

## Key facts

- **NCT ID:** NCT04585074
- **Lead sponsor:** Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-04-08
- **Primary completion:** 2025-06-30
- **Final completion:** 2030-04-07
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585074, "Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04585074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*